Lone Star Group has finalized a definitive agreement to acquire Lonza Group's Capsules and Health Ingredients (CHI) division. Lonza will retain a 40 percent equity position in the business, maintaining a minority stake. CHI operates globally across the Americas, Europe, and Asia Pacific, with three core segments: hard empty capsules, dosage form solutions, and health ingredients.

The acquisition positions Lone Star to leverage CHI's leading positions in nutraceutical and pharmaceutical markets, particularly in joint health, energy, and active lifestyle segments. CHI's strong heritage of product quality and innovation aligns with Lone Star's growth strategy, offering enhanced operational flexibility and dedicated investment to accelerate development. Lonza's retention of equity suggests a collaborative partnership approach, while Lone Star's CEO emphasizes CHI's standalone potential for greater strategic focus.

This deal reflects a strategic expansion into high-growth health ingredients, with implications for supply chain dynamics in the global nutraceutical sector.